DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Abdul-Rahim AH, Perez A, MacIsaac RL. et al. al; Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved (CHARM-Preserved) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve) Steering Committees.
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
Eur Heart J 2017;
38 (10) 742-750
Access:
We do not assume any responsibility for the contents of the web pages of other providers.